The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Quantification of walking mobility in neurological disorders
Abstract
Difficulty in walking is a major feature of neurological disease, and loss of mobility is the activity of daily living on which patients place the most value.1 Consequently, how to measure and assess this is of importance to any member of the inter-disciplinary team. In clinical practice, the World Health Organization international classification of functioning (ICF)2 is often adopted as the underlying framework for the assessment of mobility, which is an individual's ability to move about effectively in their environment.2 The ICF also introduces the constructs of performance (what an individual does in his environment) and capacity (ability to execute a task or action). This has a clear impact on the current methodology for the assessment of mobility. Different pathologies and impairments culminate in abnormal or reduced walking. For instance, in multiple sclerosis (MS), impairments such as weakness and spasticity from pyramidal tract lesions, loss of proprioception and co-ordination from dorsal column and cerebellar lesions, vestibular and visual dysfunction, cognitive and mood disturbance and pain may all contribute (Figure 1). In primary muscle disease, mobility is determined by weakness but secondary factors such as weight gain, contractures, fatigue and breathlessness may have important impacts. The degree of impairment has a non-linear relationship with activity and participation. For example leg strength and walking speed are poorly correlated,3 while many personal and environmental factors may influence the impact of similar degrees of loss of walking on mobility. Framework of international classification of function (ICF) as illustrated by mobility in MS. Impaired walking can be a marker of both disability and disease progression, and is therefore an important outcome measure in the treatment and rehabilitation of diseases such as MS and Parkinson's disease (PD). In some cases, measurement of mobility may have a direct influence on access to treatment. For example in MS, eligibility for disease-modifying drugs is in part determined by the maximum walking distance.4 Clinicians regularly observe gait for diagnostic purposes and commonly form opinions, often aided by the impression of the patient and/or carer, as to whether walking is ‘better’ or ‘worse’ in the context of progression of disease or response (or lack of it) to treatment. In the context of monitoring, it is clearly preferable to measure walking objectively. As yet, there is no ‘gold standard’ assessment that provides a direct measure of mobility in a community setting,5 i.e. performance. Current assessment of mobility (Table 1) usually involves subjective or observer-rated instruments that range from direct clinical observation to asking the patient, sometimes aided by questionnaires or diaries. Most indices provide a measure related to a specific point in time and a particular setting, and are characterized by brevity, a non-familiar environment, the need for direct observation, dependence on exact instructions, and an unquantifiable impact of the observer, which is likely to vary depending on the aim of the evaluation (e.g. assessment for social security payment vs. interferon prescription). Such measures may provide an index of what an individual can do (capacity) or believes they can do (in terms of walking), but the extent to which they indicate actual performance in the home environment is speculative. Summary of some methods of assessing walking mobility Summary of some methods of assessing walking mobility Clinical practice increasingly demands that interventions have robust outcome data and clear benefits. Many current measurement tools used in practice have limitations6 (see Table 2). We review some current methods of assessing mobility in terms of reliability, validity, responsiveness (identifies change that is significant to patient and clinician) and whether they can inform objectively on performance. Some psychometric properties of mobility measures ICC = intra-class correlation; RMI = Rivermead Mobility Index; EDSS = Expanded Disability Severity Scale; max walk = maximum walking distance; 2 min walk = distance walked in 2 min; AI = Ambulation Index; FIM = Functional Independence Measure; SF36-PF = Physical Function component of SF-36; SF-36 RP = Physical Role component of SF-36; MSWS = MS Walking Scale; GNDS (UK) = Guys/UK Neurological Disability scale; GNDS (LL) = Mobility sub-section of GNDS; MSIS-phys = Physical component of MS Impact Scale; UPDRS = Unified Parkinson's Disease Rating Scale; BI = Barthel Index; FIM = Functional Independence Measure; OPCS = Office Population Censuses Surveys. Some psychometric properties of mobility measures ICC = intra-class correlation; RMI = Rivermead Mobility Index; EDSS = Expanded Disability Severity Scale; max walk = maximum walking distance; 2 min walk = distance walked in 2 min; AI = Ambulation Index; FIM = Functional Independence Measure; SF36-PF = Physical Function component o
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Two-, six-, and 12-minute walking tests in respiratory disease.
Butland, R. J., Pang, J., Gross, E. R., Woodcock, A. A., & Geddes, D. M. (1982) · BMJ · doi:10.1136/bmj.284.6329.1607 · Cited by 1,668
Accuracy of five electronic pedometers for measuring distance walked
BASSETT, D. R., AINSWORTH, B. E., LEGGETT, S. R., MATHIEN, C. A., MAIN, J. A., HUNTER, D. C., & DUNCAN, G. E. (1996) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199608000-00019 · Cited by 552
Measurement of daily walking distance-questionnaire versus pedometer
BASSETT, D. R. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200005000-00021 · Cited by 260
Cited by
Learmonth, Y. C., Motl, R. W., Sandroff, B. M., Pula, J. H., & Cadavid, D. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-37 · Cited by 773
Physical activity and multiple sclerosis: a meta-analysis
Motl, R. W., McAuley, E., & Snook, E. M. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1188oa · Cited by 516
Impact of Walking Impairment in Multiple Sclerosis: Perspectives of Patients and Care Partners
LaRocca, N. G. (2011) · The Patient: Patient-Centered Outcomes Research · doi:10.2165/11591150-000000000-00000 · Cited by 507
Motl, R. W., Cohen, J. A., Benedict, R., Phillips, G., LaRocca, N., Hudson, L. D., Rudick, R., & Multiple Sclerosis Outcome Assessments Consortium (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517690823 · Cited by 407
The benefits of exercise training in multiple sclerosis
Motl, R. W., & Pilutti, L. A. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.136 · Cited by 394
Metadata
- Authors
- Pearson, O. R., Busse, M. E., van Deursen, R. W. M., & Wiles, C. M.
- Venue
- QJM
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-07-15
- Volume
- 97
- Issue
- 8
- Pages
- 463-475
- ISSN
- 0033-5622 (ISSN-L)
- 1460-2725
- 1460-2393
- OpenAlex
- W2114060341
- Cited by
- 181
- References
- 4
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quantification of walking mobility in neurological disorders. https://app.cochat.ai/papers/10.1093/qjmed/hch084
- The paper
- Pearson, O. R., Busse, M. E., van Deursen, R. W. M., & Wiles, C. M. (2004). Quantification of walking mobility in neurological disorders. QJM. https://doi.org/10.1093/qjmed/hch084
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.